Corporate News Report – Advanced Biomed (ADVB) and Peer Performance
Advanced Biomed (ADVB)
- Trading session: Down 1.05 % during a 24‑hour period ending 04:05 PM Central Europe on Thursday 22 Oct 2026.
- Current share price: USD 3.64.
- Shares outstanding: 1.7 million.
- Market capitalization: USD 6.30 million.
- 24‑hour volume: USD 95.10 k.
- Month‑to‑date performance: Down 41.07 % since the end of September 2026.
- Technical indicator: Simple moving average (200 days) at USD 6.06.
- 52‑week range: Highest at USD 24.23 (24 Jul 2026); lowest at USD 3.15 (21 Oct 2026).
Peer Performance (last 24 hours)
| Symbol | Company | % Change | Current Price (USD) | Market Capitalisation (USD) |
|---|---|---|---|---|
| ARBB | Arb Iot | –3.11 % | 3.90 | 7.20 million |
| XHLD | Ten | +52.44 % | 0.90 | 7.10 million |
| SKYE | Skye Bioscience | +0.62 % | 1.63 | 7.20 million |
| LUCY | Innovative Eyewear | +4.45 % | 0.86 | 7.20 million |
| APRE | Aprea Therapeutics | –0.18 % | 0.53 | 7.10 million |
Ten (XHLD) Key Corporate Development
Ten Holdings Inc. (XHLD) announced that its chairman and CEO, Virgilio Torres, will address investors in a live webinar on 27 Oct 2026. The event, part of the Skyline Signature Series, will discuss the company’s Digital Experience Platform (TEN) and plans to expand into AI, automation, and advanced analytics. A Q&A session will follow the presentation. The company described the webinar as a means to strengthen communication with shareholders and demonstrate transparency. This initiative aligns with Ten’s strategy to broaden its platform beyond event‑centric solutions and enhance offerings for enterprise clients.
Skye Bioscience (SKYE) Institutional Activity
Recent filings in the German Federal Gazette disclose that several institutional investors hold short positions in Skye Bioscience shares. Positions range from just over 0.5 % to approximately 0.6 % of outstanding shares. The disclosures, made in August and early September, indicate ongoing monitoring by these investors. Skye Bioscience has not issued any commentary regarding these positions.
All figures are reported as of the close of the 24‑hour period ending 04:05 PM Central Europe, Thursday 22 Oct 2026.
